ICAM1 and neoplasm: Prospectively, a combination of inflammatory factors (such as TNF-α) and adhesion molecules (such as ICAM1 and ALCAM) neutralizing antibodies might be a useful adjuvant therapy to prevent tumor metastasis in the process of tumor treatment.